medric medric
잠시만 기다려 주세요. 로딩중입니다.

In silico drug repositioning: from large-scale transcriptome data to therapeutics

Archives of Pharmacal Research 2019년 42권 10호 p.879 ~ 889
 ( Kwon Ok-Seon ) - Seoul National University College of Pharmacy

 ( Kim Wan-Kyu ) - Ewha Womans University Department of Life Sciences
 ( Cha Hyuk-Jin ) - Seoul National University College of Pharmacy
 ( Lee Hae-Seung ) - Ewha Womans University Department of Life Sciences


Drug repositioning is an attractive alternative to conventional drug development when new beneficial effects of old drugs are clinically validated because pharmacokinetic and safety profiles are generally already available. Since ~?30% of drugs newly approved by the US food and drug administration (FDA) are developed through drug repositioning, identifying novel usage for existing drugs is an emerging strategy for developing disease treatments. With advances in next-generation sequencing technologies, available transcriptome data related to diseases have expanded rapidly. Harnessing these resources enables a better understanding of disease mechanisms and drug mode of action (MOA), and moves toward personalized pharmacotherapy. In this review, we briefly outline publicly available large-scale transcriptome databases and tools for drug repositioning. We also highlight recent approaches leading to the discovery of novel drug targets, drug response biomarkers, drug indications, and drug MOA.


Drug repositioning; In silico drug repositioning; Transcriptome; Pharmacogenomics; Big data
원문 및 링크아웃 정보
등재저널 정보